Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Top Cited Papers
- 16 February 2010
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Neurology
- Vol. 6 (3), 131-144
- https://doi.org/10.1038/nrneurol.2010.4
Abstract
No abstract availableKeywords
This publication has 137 references indexed in Scilit:
- Absence of Pittsburgh Compound B Detection of Cerebral Amyloid β in a Patient With Clinical, Cognitive, and Cerebrospinal Fluid Markers of Alzheimer DiseaseArchives of Neurology, 2009
- Cerebrospinal fluid tau and ptau 181 increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's diseaseEMBO Molecular Medicine, 2009
- Detection of amyloid in Alzheimer’s disease with positron emission tomography using [11C]AZD2184European Journal of Nuclear Medicine and Molecular Imaging, 2009
- Prediction and longitudinal study of CSF biomarkers in mild cognitive impairmentNeurobiology of Aging, 2009
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjectsAnnals of Neurology, 2009
- The neuropathology of probable Alzheimer disease and mild cognitive impairmentAnnals of Neurology, 2009
- A γ‐secretase inhibitor decreases amyloid‐β production in the central nervous systemAnnals of Neurology, 2009
- Phase 2 Safety Trial Targeting Amyloid β Production With a γ-Secretase Inhibitor in Alzheimer DiseaseArchives of Neurology, 2008
- Alzheimer's diseaseThe Lancet, 2006
- Frontotemporal dementia: Clinicopathological correlationsAnnals of Neurology, 2006